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The annual absolute number of cardiovascular implantable
devices (CIEDs) is steadily increasing and is expected to rise
even further, mostly due to the ageing demographic changes.
[1] Consequently this will have a major impact on the post-
implantation follow-up of monitor device function and patient
condition both in terms of time and personnel. In a recent
survey in 14 European countries remote monitoring (RM) was
used in about 85% of all centres and the responding centres
estimated that this percentage will increase to 93% by 2015.
[2] In the same survey, guidelines and/or recommendations for
the use of RM available from national scientific societies were
reported to be totally absent in 93%. This lack of structural
guidelines and/or recommendations will undoubtedly lead to a
wide heterogeneity among centres using RM for the optimal
care of patients after implantation. In addition responsibility
related to remote follow-up is not clearly defined and leaves
the device specialist and allied professionals in doubt with
respect to the legal issues of RM. In 2009 the Netherlands
Heart Rhythm Association (NHRA) took the initiative to
develop a consensus document for RM in order to make a
more uniform approach for RM and remote follow-up of the
device patient.
Close to 60 individuals have contributed to this expert
consensus report. All aspects related to RM were divided
into subgroups focussing on well-defined issues. The fol-
lowing subgroups were defined:
1. Description of remote CIED monitoring
2. Indications, benefits and limitations of remote CIED
monitoring
3. Patient perception of remote CIED monitoring
4. Contribution of manufacturer to remote CIED
monitoring
5. Costs and reimbursement of remote CIED monitoring
6. Preliminary recommendations for remote CIED
monitoring
For each subgroup a working group was formed. For
each working group a chairperson was appointed and 5
to 8 members were carefully selected based on personal
experience and individual expertise in the field. During
half-day sessions working groups focussed on their spe-
cific subject which resulted in a concept document which
was subsequently distributed by the chairperson for ad-
ditional review.
All sessions were also attended by the first three authors
of the final expert consensus documents (CdC, JE and NvH)
for process surveillance without interference with the con-
tents. Finally the concept consensus report was reviewed
during half-day sessions with all chairpersons.
Despite the fact that RM was introduced more than
10 years ago, guidelines are available in only 5% of Euro-
pean countries, although RM is already widely implemented
in medical practice. [2]
A uniform approach to patients with CIED permitting
RM is essential for a safe and optimal treatment. Clear and
standardised information to the patient is also needed for
optimal transmissions.
C. C. de Cock (*)
Department of Cardiology, VU University Medical Center,
Boelelaan 1117,
1081 HV, Amsterdam, the Netherlands
e-mail: cc.dcock@vumc.nl
J. Elders
Department of Cardiology, Canisius Wilhelmina Hospital,
Weg door Jonkerbos 100,
6500 GS, Nijmegen, the Netherlands
N. M. van Hemel
Heart Lung Center, Utrecht University,
P.O. Box 80125, Utrecht, the Netherlands
Neth Heart J (2012) 20:51–52
DOI 10.1007/s12471-011-0240-z
In the CONNECT trial up to 45% of all alerts were not
transmitted simply because the setup of the system was
inappropriate.[3] In the Dutch expert consensus document
a brochure is presented with patient instructions and educa-
tion emphasising the responsibilities of the patient with
respect to RM. [4]
In addition a minimal set of parameters and alerts has
been defined which may impose early medical treatment and
prevent appropriate and inappropriate shocks. [5] Further-
more the introduction of RM into a device clinic needs a
tailored organisation with structured appointments on sched-
uled or unscheduled visits, reason and type of device reprog-
ramming etc. Of interest, the present expert consensus
document has made a clear statement that RM can and will
not be capable to be used as a 24/7 emergency system.
The Heart Rhythm Society/European Heart Rhythm As-
sociation expert consensus document on monitoring of
CIEDs was published in 2008 and lacks a clear statement
on 24/7 surveillance, which fuelled concern with respect to
legal issues for alerts.
Finally, reimbursement will be a key issue for a wide
implementation of RM. For private insurance companies
and national health services the major challenge is in dem-
onstrating improved health care with no rise in health rise
costs. [6] In 82% of the countries in Europe there is no
reimbursement structure despite the fact that preliminary
studies demonstrated the cost effectiveness of RM and a
high patient acceptance and satisfaction. [7] More prospec-
tive studies are needed with health economic costs as one of
the primary endpoints before RM will be standard of care
for all patients after device implantation. [8, 9]
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